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-.... -- ...,_ -Ficure 1: Primtr, for PCR

C022 is• gtne that codes for ,1 pn:,tt1n by tht s.1me ~me This protem 1s
no~lly oprnsed on tl\t ~ of k~ll. whert 1t p.irtlopiltH in the
ctlrs ~ In ~ttd studif!s. CD22 ~ bttn shown to •PPHr on
cancerous lung ceGs.. It a ~ that ttus rS also true for can"rous
anNn and pmcrHbC ~ d'-" to a

~ ;1bnormi1lity common to

•II of tht1.e anctn.

The pntNry hypothests a that iNppropNte KtMtlOn of the (022 aene
ar,es ,1 tumor cd Ml ~tart to ffif!OSU:S&S to tymph nodes ,1nd bone.
This resHrth tl5S thts hypothts,i:s by comp,ilnng the e.xp~n of CD22
Up"'5,,S,10n on B-aO WW1 'NM ~r.il owmn cancer ctll Ii~ to detenmne
o : ~ P i l ~ Ind by CNIXttnZJtlOf'I of nonNI and •bernnt CD22
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Fiturt 3: Flow Cytornetry
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This reseMCh MS Vf'.ll scn,fiata. It WIii pnMde valuable inform,1tion
on the exprt'SSion of CD22 on tumors. wh,ch an m tum be used ,1s a ~
t'if1'l for ,nt.body darmed ~PY Anbbody thMapy for this protein ;also
~s IT"•t poW'lbll \ti ~ V1d pil~•tJC anctn. a s it ,s t-a11ortd with
lffilN" ~ o t y tNn rn.,y a...fflT. QrUf trHU'Mnts
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through CD22 hom1nc rfU'Pt(W KtMty prcMchnc a mtta:statx: iCMnug, to
the " II, wh1Ch rl a part of whit this research Sttks to determine.
Hypothesb

The centnil hypothnn rs tNt tUfflOf c.efts w,th a rearrangement 1n the
re1k>n of chromosome 19qU ~ in Jdvin~e to meu staSJs to lymph
nodH ind bone This rnHrch tf'StS tM hypothn,s by compannc the

PA· l ovarian cells are the onty cells that haw been an,lyted thus f.1r V\a
flow cytometrv. The d1Hertnc.t ,n muns be1wttn the lc(j PA-1 controA Jnd
the PA· 1 C022 population ~nds conf.cSence to C022 surface uprtssk>n In
this cell line. Flow cytometry hills yet to bit oot1m1zed for 1h11 experlrMnt, and
more cell lines and neptive controls will bf analyud U\lnl now cvtom«try
Hela, the ne1at1ve control used. pr ~ to be a poor control upon Row
cytomet,v.

«tNl•N:IIOl".Mtontrol_,tht~k.
bClct, lt,all'Of,ttfl ttld'CMQflCfflMuvtnanc.fh. r-

~~am luc1val-.w11r • o ~ ~

What r1 CD2l?
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"'&ri111lflf Plli•1 n,m, lhffl:.alo,w,rcounu to,boctlWrl CD2..2•1'1dthttonllOlr1~tothf
. . _ ., tM<f'll • d.~t111lhtmt~CDUlrKJffC,A~lhntoc,c,,.NbOt1$
s.mil,ttyto , - h , 1 w n ~ 111 tMbmcn~thtU1"111111~ ,lowf,, mt1t1WtlthtCD2.l

(022
cene tNt c:ode for ,1 Qrbohydrite bmd1ng lectin protein wh1th
11 ilso ailed Bl,<AM ~r.c KJd bl:nd<"11&-H:e lKtlll 2. This protein tS
normally__....., on !he OUltf nwml><>ne suma of 8-lymphocytos,
WMrt 1t pal'tlOpat.ts tn 8-all $,W'Vl'V3J. In r, i.te-d stud.es, C022 illS bttn
shown to Jppur on Qf'IUfOUS lune crlls Thrs study IS performe-d under the
hypothHas tNt thrs rs i:l,0 true for a ~ ~ Nn ind pancrutlC cells
t>K.iuse of ill chromosome 11:JinonNhty common in ill of the
Jfortmenboned ancm C022 may mo part1CJp.iite 1n boM meustaSts
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Wh.1t Has Been Obserwd So Far
In qualrtative anatys1s of the total RNA prior to pef"fOl'mlnc rwerw
t~nscription (Figure 2a), thue .1re two ~ nch J nd tvldtnce ot rlbo1omaJ
RNA at Vilt"yine lengths, 1ndatm1 the RNA rs ,nuct it this met Ficure lb
depicts a gtl th.1t wu run f0Uowln1 rtwrse tr.1nscrlpt1on and PCR
amphfkation. While fainter compared to the ~mos lkell) band. I definite
b.1nd Is pre-sent for the PA· l cONA. This U5'ef'U th.at C022 Is v:prnsed
fnappropnatety In cancerous PA·l ovarian ctlls. howeYer, 1111 not exprniec,
at the levels seen In tht Ramos ctlls
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Tissue Culture
A mammalian cell tissue culture was performed on two cancerous ovarian cell lints (PA· l). These cell lines were 1rown and
maintained under st!rilt conditk>ns in an environmentilty controlled chaimber with a S" carbon dk>xide atmcnphere at
3TC. These cells were grown using DMEM medium, fetal bovine serum (f6S), and antib.Otic.s.
Primer Desicn
Primers for this procedure were designed by util1zin1 NC Bi's Primer-BLAST function; pnmers anew tarceting of the desirtd
gene prodlJCt. In this case, that gtne is C022. The introns for this gene were mapped to determine the coding re1ions of
(022. (Figure 1).

e11preu10n of CD22 oprHSK>t'I on a-aa lanes w th stYtnil ownan anur

Reverse Transaiptase Potymense Chain Ruction (RT PCR)

cell Imes to determine expression patttrns ind by charactet1zat1on of
normal ind abtrnnt CD22 ff<tl)tof" substrate 1nterxt10ns on bent marrow
strOf'Nlctlls

A sample of the PA-1 cell line was harvested for RNA, which was punfied, quantrtated using a nanodrop, and assessed for
quality via gel electrophorHIS (Figure 2a) All of the samplfi in this experiment were stained UJJnl GelRed A ladder was run
in each gtl as a method of mtasunng the lengths of tht samples. The RNA was then rf'Vtrse trans.c:nbed to cDNA thtn the
sptcific CD22 sequence was amphf1ed by us1ng an upstream and a downstream primer des1gntd for (022, whlCh span an
intton. Anothtr gel was run on the cDNA prodlKt (Figure 2b).

Reb1ted Rese.uch
Vinous stud,es provide evtdence for C022 bt1l"'i ill potent.al muttr
potent111 an11body treatment for lune c,nct>r (Tl.llC.I
f'l ii 2012

rt~1rch Is controversial, though, u one study (Poi et at 20141 p
uN ble to tirget CD22 w,th their ~lf't'.ed i1nt bodi
Alm of this resurt h
This resurch sttks to provldt 1ns1ght 1n10 thl" i1be
C022 on tumors Th11 inform.t.,on an be

prott1n to Jt\O i11C1 ~\ a t
c.incrr1
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Flow Cytometry
Flow cytomttry 1nvotves a laser-based technology :r, <e!J co~--.:.ng. sorting. and b,omarker detection analysis. The flow
i1natys1s 1s being ~rformed on a ll«iUTia"I Cou:ter C~'tCf!~, .\:.a",;:s ,s performed by suspending cells in isotonk solution,
a1mng with nuorescentty labeled ant;boc
an:; 1~en ~na:,.-u,g 1ne cp!ls on th!! mm ument. The cell lines are anJtyzed
<1 the ~mt det ector settin&s In this study, no,... C)!~ -r,t•r1 s bt ~g used to assess the frequency of C022 sur1Ke
'"' anc.rrous ovarian eel ' •nt1 (Figurr 31 ~r-".,.) tf:b ,1re- used as ,1 positive control for C022 surface expresSJon,
c·1ntrol for nonsi,tcific b,nding by u·.e tr: ::::vd1
Northtrn and \'/es-tern Bloninz
Nonhtrn blctt.n;,.,, t, u1 , :
anafys,s 1s unablt to anJtvze this, .,..r ..•
the mRNA of the S-cell (Ramos), this rr. ,,
the length of C022 on the surface of tl'\e o,·

t~~-· ~,s .,..ould te:1 us if rt 1s the appropnate sued ~nscript PCR
• citrlorrr.mg a Northern blot. If the mRNA 1s a different size than
c.f rve-st1gat10n. Western blorung will be used to determine

Where This Study Will Go In the Fvturt
This preliminary study has a lot of sp,ac.e to continue New cells !Inti and
controls will bt explored, and PCR will be performed on thne, one such cell
line being CaOVl. Tht PCRproc:IUCU wlll be wqutnctd to confirm the rtSUIU
In ordtr to proceed i nd conskSer the PCR sucuuful. the SfqutnU mutt
mi1tch that of CD22. Northern ind wenem blottlrc rT\<1'f bt ~med ,n the
near future. To fully addren the primi11ry ~
s,\ of th1.s rtSe.ardl, the
functionality of C022 on thHe cells will al:so nttd to bt aplortd. Fvwre
e•perimenu would test the adhes,on of C022 expr~.sinc cen.s to bone
marrow stromal cells. Should this research come to the condus,on that the
hypothesis was accur1te, animal tntlnc and d1nial tNk would be amonc
the final assessments of CD22 as a viah'e tarpt fOI' arruboay thtrapy
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